To validate that our CRC metastasis model also resembles the clinical situation in terms of stem cell-like characteristics, we stained primary tumor cells, liver metastases and PC with antibodies against the stem cell markers CD44, CD133, and c-Myc (Figure 4A). Here, MYC is linked to colorectal carcinoma.